THE CANNABIST COMPANY HOLDINGS INC. Financials The Cannabist Company Holdings Inc. NEO Exchange
Equities
CBST
CA13765Y1034
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.41 CAD | -3.53% |
|
-2.38% | -30.51% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 538.3 | 1,756 | 1,076 | 309.3 | 193.5 | 132.8 | - | - |
| Enterprise Value (EV) 1 | 497.1 | 1,991 | 1,415 | 828.4 | 704.1 | 622.3 | 579.1 | 132.8 |
| P/E ratio | -5.08 x | -12.6 x | -6.81 x | -0.71 x | -1.05 x | -1.67 x | -3.32 x | -4.14 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.95 x | 9.78 x | 2.27 x | 0.6 x | 0.38 x | 0.26 x | 0.23 x | 0.19 x |
| EV / Revenue | 6.42 x | 11.1 x | 2.99 x | 1.62 x | 1.38 x | 1.23 x | 1 x | 0.19 x |
| EV / EBITDA | -10.6 x | -481 x | 16.6 x | 12.3 x | 10.1 x | 8.13 x | 5.54 x | 1.16 x |
| EV / FCF | -3.62 x | -23.3 x | -12 x | -4.5 x | -282 x | 7.23 x | 57.9 x | - |
| FCF Yield | -27.6% | -4.29% | -8.34% | -22.2% | -0.35% | 13.8% | 1.73% | - |
| Price to Book | - | 4.9 x | 1.76 x | - | 2.81 x | 2.42 x | -14.5 x | -2.07 x |
| Nbr of stocks (in thousands) | 2,16,199 | 2,90,319 | 3,76,209 | 4,12,452 | 4,30,221 | 4,58,024 | - | - |
| Reference price 2 | 2.490 | 6.050 | 2.860 | 0.7500 | 0.4498 | 0.2899 | 0.2899 | 0.2899 |
| Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 77.46 | 179.5 | 473.8 | 511.6 | 511.3 | 507.1 | 580.6 | 689.7 |
| EBITDA 1 | -46.94 | -4.138 | 85.07 | 67.38 | 69.64 | 76.56 | 104.4 | 114.2 |
| EBIT 1 | -92.89 | -74.1 | -110.4 | -113.5 | -105.2 | -9.862 | 42.25 | 59.9 |
| Operating Margin | -119.92% | -41.28% | -23.29% | -22.18% | -20.58% | -1.94% | 7.28% | 8.68% |
| Earnings before Tax (EBT) 1 | - | -136.9 | -146.7 | -432.7 | -168.9 | -63.86 | 9.7 | 28.6 |
| Net income 1 | -102.6 | -110.8 | -143.1 | -416 | -175.7 | -96.91 | 7.2 | 21 |
| Net margin | -132.44% | -61.71% | -30.2% | -81.32% | -34.36% | -19.11% | 1.24% | 3.04% |
| EPS 2 | -0.4900 | -0.4800 | -0.4200 | -1.060 | -0.4300 | -0.1737 | -0.0873 | -0.0700 |
| Free Cash Flow 1 | -137.2 | -85.49 | -118 | -184.1 | -2.495 | 86.04 | 10 | - |
| FCF margin | -177.11% | -47.63% | -24.91% | -35.99% | -0.49% | 16.97% | 1.72% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | 112.38% | 9.58% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | 138.89% | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 139.3 | 123.1 | 129.6 | 132.7 | 126.2 | 124.5 | 129.2 | 129.2 | 128.4 | 122.6 | 124.5 | 125.9 | 129.3 |
| EBITDA 1 | 27.21 | 16.83 | 12.03 | 20.99 | 17.4 | 16.36 | 20.32 | 20.49 | 12.47 | 15.3 | 17.78 | 19.6 | 21.37 |
| EBIT 1 | -84.84 | -14.66 | -22.11 | -18.71 | -58 | -8.269 | 0.049 | -19.33 | -77.69 | -10.74 | -3.934 | -1.229 | 2.582 |
| Operating Margin | -60.92% | -11.91% | -17.06% | -14.1% | -45.96% | -6.64% | 0.04% | -14.96% | -60.52% | -8.76% | -3.16% | -0.98% | 2% |
| Earnings before Tax (EBT) 1 | -53.89 | -27.27 | -35.55 | -31.73 | -338.1 | -25.88 | -22.73 | -33.88 | -86.4 | -25.7 | -17.14 | -14.53 | -11.37 |
| Net income 1 | -53.28 | -26.64 | -53.83 | -35.43 | -300.1 | -37.34 | -28.86 | -36.72 | -72.78 | -35.07 | -22.76 | -21.24 | -18.85 |
| Net margin | -38.25% | -21.64% | -41.54% | -26.69% | -237.83% | -29.98% | -22.33% | -28.43% | -56.7% | -28.61% | -18.28% | -16.87% | -14.57% |
| EPS 2 | -0.1400 | -0.0700 | -0.1400 | -0.0900 | -0.7500 | -0.0900 | -0.0700 | -0.0900 | -0.1800 | -0.0800 | -0.0500 | -0.0500 | -0.0400 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 14/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 29/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 13/03/24 | 09/05/24 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 234 | 339 | 519 | 511 | 490 | 446 | - |
| Net Cash position 1 | 41.3 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -56.57 x | 3.987 x | 7.704 x | 7.331 x | 6.394 x | 4.273 x | - |
| Free Cash Flow 1 | -137 | -85.5 | -118 | -184 | -2.5 | 86 | 10 | - |
| ROE (net income / shareholders' equity) | -43.6% | -25.3% | -32.6% | -30.9% | - | - | - | - |
| ROA (Net income/ Total Assets) | -32.3% | -12.7% | -13.6% | - | - | - | - | - |
| Assets 1 | 318.1 | 873.3 | 1,052 | - | - | - | - | - |
| Book Value Per Share 2 | - | 1.240 | 1.630 | - | 0.1600 | 0.1200 | -0.0200 | -0.1400 |
| Cash Flow per Share 2 | -0.2800 | -0.1800 | - | - | - | 0.0700 | 0.1000 | - |
| Capex 1 | 77.4 | 42.9 | 118 | 72.7 | 9.97 | 18.1 | 11.4 | 10 |
| Capex / Sales | 99.98% | 23.89% | 24.8% | 14.22% | 1.95% | 3.56% | 1.96% | 1.45% |
| Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
0.2899
USD
Average target price
1.038
USD
Spread / Average Target
+258.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 339M | |
| +34.02% | 281M | |
| +30.45% | 263M | |
| +39.83% | 187M | |
| +164.52% | 150M | |
| +46.09% | 134M | |
| -28.57% | 121M | |
| -7.69% | 80.17M | |
| +100.00% | 60.26M |
- Stock Market
- Equities
- CBSTF Stock
- CBST Stock
- Financials The Cannabist Company Holdings Inc.